Postoperative radioiodine ablation does not reduce cancer recurrence following thyroidectomy
1. The 5-year recurrence-free survival was comparable with ablation and without ablation. 2. Adverse events were comparable in both groups, ...
Tag: thyroid malignancy
#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers
Click to read this study in the Journal of Clinical Oncology.
